It’s hard to ignore the seismic shifts brought about by algorithm-driven content. Every time you scroll through your social media feed or check your favorite news app, algorithms are diligently at ...
SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from ...
Sarepta (SRPT) stock moved higher after early siRNA trial data showed muscle delivery, biomarker activity, and favorable safety in muscular dystrophy programs. Sarepta stock moved higher after ...
Sarepta Therapeutics stock rose 5% after hours as the company announced January 26 release of 3-year Elevidys data following recent FDA safety warnings. Sarepta Therapeutics will present 3-year data ...
Hosted on MSN
Why is SRPT stock falling today?
Sarepta is set to exchange 1.25% convertible senior notes due 2027 for new 4.875% convertible senior notes due 2030, alongside about $31.6 million in cash. The transaction is slated to be completed ...
The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...
We recently published 12 Stocks Jim Cramer Discussed As Analyzed Morgan Stanley’s Comments. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the stocks Jim Cramer recently discussed. Sarepta ...
Sarepta Therapeutics stock (NASDAQ: SRPT) experienced a significant turnaround on Wednesday, with shares rising 33% in after-hours trading following the announcement of an extensive restructuring plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results